医薬品ロジスティクス市場- 世界の産業規模、シェア、動向、機会、予測、タイプ別、コンポーネント別、地域別、競合、2019年～2029年

医薬品ロジスティクスの世界市場規模は2023年に932億3,000万米ドルで、予測期間中のCAGRは7.09%で2029年には1,408億3,000万米ドルに達すると予測されています。

世界の医薬品ロジスティクス市場は、医薬品やヘルスケア製品をタイムリーに届けるための効率的なサプライチェーン・ソリューションに対する需要の高まりにより、大きな成長を遂げています。eコマースの台頭により、ロジスティクス分野は製薬会社と消費者双方のニーズに対応し、サプライチェーン全体の可視性と追跡機能を強化しています。医薬品には厳格な安全・品質基準が適用されるため、この市場では規制遵守が最も重要です。そのため、ロジスティクス・プロバイダーは、温度管理された輸送、先進パッケージング・ソリューション、特殊なハンドリング・プロセスに投資し、製造からエンドユーザーへの配送まで製品の完全性を確保しています。特定の保管条件を必要とすることが多い生物製剤やバイオシミラーの普及は、専門的なロジスティクス・サービスに対する需要をさらに煽っています。COVID-19パンデミックは、弾力性のあるサプライチェーンの重要性を浮き彫りにし、ロジスティクス・インフラとテクノロジーへの投資の増加につながった。企業は、ルートの最適化、コスト削減、サービス提供の改善のために、自動化、人工知能、データ分析をますます活用するようになっています。市場はまた、持続可能な慣行へのシフトを目の当たりにしており、ロジスティクス・プロバイダーは二酸化炭素排出量を最小限に抑えるために環境に優しいソリューションを導入しています。地域的には、大手製薬会社と先進的な物流インフラが存在する北米が医薬品ロジスティクス市場を独占しています。アジア太平洋地域は、ヘルスケア分野の拡大と可処分所得の増加に牽引され、急速に台頭しています。医薬品メーカーとロジスティクス・サービス・プロバイダーの連携は、複雑な世界・サプライチェーンを乗り切る上で極めて重要です。医薬品市場が進化を続ける中、ロジスティクス市場は新たな動向に適応し、規制状況の遵守を維持しながら、患者が必要な医薬品を迅速かつ安全に受け取れるようにしなければなりません。このダイナミックな環境は、医薬品ロジスティクスエコシステム全体の利害関係者に課題と機会の両方をもたらします。

市場促進要因

医薬品需要の増加

eコマースの成長

技術の進歩

生物製剤とバイオシミラーの台頭

主な市場課題

温度管理

持続可能性への圧力

主な市場動向

コールドチェーン物流への注目の高まり

eコマースの拡大

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の医薬品ロジスティクス市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別（コールドチェーン物流、非コールドチェーン物流）
  • コンポーネント別（保管、輸送、モニタリングコンポーネント）
  • 地域別
  • 企業別（2023）
• 市場マップ

第6章 北米の医薬品ロジスティクス市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別
  • コンポーネント別
  • 国別
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の医薬品ロジスティクス市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別
  • コンポーネント別
  • 国別
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域の医薬品ロジスティクス市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別
  • コンポーネント別
  • 国別
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の医薬品ロジスティクス市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別
  • コンポーネント別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの医薬品ロジスティクス市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別
  • コンポーネント別
  • 国別
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併および買収（該当する場合）
• 製品の発売（該当する場合）
• 最近の動向

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Agility
• United Parcel Service of America, Inc.
• VersaCold Logistics Services
• CEVA Logistics
• Air Canada
• DB SCHENKER
• Deutsche Post AG
• FedEx
• LifeConEx
• Marken

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Pharmaceutical Logistics Market was valued at USD 93.23 Billion in 2023 and is expected to reach USD 140.83 Billion by 2029 with a CAGR of 7.09% during the forecast period.

The Global Pharmaceutical Logistics Market is experiencing significant growth, driven by the increasing demand for efficient supply chain solutions to ensure the timely delivery of medications and healthcare products. With the rise of e-commerce, the logistics sector is adapting to meet the needs of both pharmaceutical companies and consumers, enhancing visibility and tracking capabilities throughout the supply chain. Regulatory compliance is paramount in this market, as pharmaceutical products are subject to stringent safety and quality standards. Consequently, logistics providers are investing in temperature-controlled transportation, advanced packaging solutions, and specialized handling processes to ensure product integrity from manufacturing to end-user delivery. The proliferation of biologics and biosimilars, which often require specific storage conditions, is further fueling demand for specialized logistics services. COVID-19 pandemic highlighted the critical importance of resilient supply chains, leading to increased investment in logistics infrastructure and technology. Companies are increasingly utilizing automation, artificial intelligence, and data analytics to optimize routes, reduce costs, and improve service delivery. The market is also witnessing a shift towards sustainable practices, with logistics providers implementing eco-friendly solutions to minimize their carbon footprint. Geographically, North America dominates the pharmaceutical logistics market due to the presence of major pharmaceutical companies and advanced logistics infrastructure. Asia-Pacific region is emerging rapidly, driven by expanding healthcare sectors and rising disposable incomes. Collaboration between pharmaceutical manufacturers and logistics service providers is crucial for navigating the complexities of global supply chains. As the pharmaceutical landscape continues to evolve, the logistics market must adapt to emerging trends, ensuring that patients receive essential medications promptly and safely while maintaining compliance with regulatory requirements. This dynamic environment presents both challenges and opportunities for stakeholders across the pharmaceutical logistics ecosystem.

Key Market Drivers

Increasing Demand for Pharmaceuticals

The increasing demand for pharmaceuticals is a significant driver of growth in the Global Pharmaceutical Logistics Market. As the prevalence of chronic diseases rises alongside an aging population, the need for timely access to medications has never been greater. This heightened demand compels pharmaceutical companies to enhance their supply chain efficiency, ensuring that products are delivered promptly and in optimal condition. Logistics providers play a crucial role in this process, offering specialized services that cater to the unique requirements of pharmaceuticals, including temperature-controlled transportation and secure storage. For instance, in September 2024, MD Logistics, a subsidiary of NIPPON EXPRESS HOLDINGS, announced the transformation of an 18,500m2 area in its Plainfield, Indiana warehouse into a state-of-the-art facility dedicated to life sciences and pharmaceuticals. This upgraded facility aims to enhance the quality of pharmaceutical logistics services, catering specifically to the needs of the industry. The rapid expansion of e-commerce in the pharmaceutical sector necessitates advanced logistics solutions to facilitate direct-to-consumer deliveries. As healthcare systems evolve to meet patient needs, the demand for reliable, efficient, and compliant logistics services will continue to escalate, driving innovation and investment in the pharmaceutical logistics sector. This trend underscores the critical importance of logistics in ensuring patient access to essential medications.

E-commerce Growth

The growth of e-commerce is reshaping the Global Pharmaceutical Logistics Market, creating new opportunities and challenges for logistics providers. The rise of online pharmacies and direct-to-consumer models, accelerated by the COVID-19 pandemic, has significantly increased the demand for efficient logistics solutions. Consumers now expect swift and reliable delivery of medications, necessitating advanced supply chain management practices that can handle the complexities of e-commerce, such as real-time tracking, order fulfillment, and last-mile delivery. The need for compliance with regulatory requirements, particularly for prescription medications, adds another layer of complexity to pharmaceutical logistics. As e-commerce continues to expand, logistics providers are increasingly investing in technology and infrastructure to enhance their capabilities, ensuring that they can meet consumer demands while maintaining the integrity and safety of pharmaceutical products. This trend not only fosters innovation within the logistics sector but also emphasizes the critical role of efficient distribution in improving patient access to essential healthcare products. For instance, in 2022, Agility Logistics announced the merger of its digital freight forwarding division, Shipa Freight, with Barcelona-based iContainers. This strategic move aims to strengthen Agility's position in the digital logistics sector by combining the technological capabilities and expertise of both companies. The merger is expected to enhance service offerings, streamline operations, and expand market reach, particularly in Europe and other key regions. By integrating Shipa Freight's digital platforms with iContainers' established network, Agility aims to provide more efficient, customer-centric solutions for international freight forwarding, catering to the evolving needs of businesses in an increasingly digital and globalized market.

Technological Advancements

Technological advancements are revolutionizing the Global Pharmaceutical Logistics Market by enhancing efficiency, transparency, and reliability throughout the supply chain. Innovations such as automation, artificial intelligence (AI), and the Internet of Things (IoT) are transforming traditional logistics practices. Automated systems streamline inventory management, reducing errors and optimizing stock levels, while AI algorithms analyze data to improve demand forecasting and route optimization. IoT devices enable real-time tracking of shipments, ensuring temperature-sensitive medications are maintained within required conditions, thus preserving their efficacy. The blockchain technology offers enhanced traceability and security, allowing stakeholders to verify the authenticity of pharmaceutical products and comply with regulatory standards. As logistics providers increasingly adopt these technologies, they can offer more responsive and agile services, ultimately improving the delivery of pharmaceuticals to patients. This technological evolution not only enhances operational efficiency but also fosters greater trust among consumers and healthcare providers, further driving growth in the pharmaceutical logistics sector.

Rise of Biologics and Biosimilars

The rise of biologics and biosimilars is a significant factor driving growth in the Global Pharmaceutical Logistics Market. Biologics, which are complex molecules derived from living organisms, and their biosimilar counterparts require specialized handling and storage conditions to maintain their integrity and efficacy. This demand for meticulous logistics solutions necessitates temperature-controlled transportation and advanced packaging techniques, ensuring that these sensitive products remain stable throughout the supply chain. As the prevalence of chronic diseases and autoimmune disorders increases, the demand for biologics is expected to grow, prompting pharmaceutical companies to seek reliable logistics partners adept at managing these complexities. The regulatory landscape surrounding biologics and biosimilars is stringent, necessitating compliance with Good Distribution Practices (GDP). As logistics providers adapt to these challenges, they play a critical role in facilitating access to these innovative therapies, ensuring that patients receive timely and safe deliveries of essential biologic and biosimilar medications.

Key Market Challenges

Temperature Control

Temperature control is a critical aspect of the Global Pharmaceutical Logistics Market, especially for the transportation and storage of temperature-sensitive products such as biologics, vaccines, and certain medications. Maintaining the required temperature range throughout the supply chain is essential to ensure the efficacy and safety of these products. Any deviation from the specified temperature can compromise the integrity of the pharmaceuticals, leading to potential patient safety risks and financial losses for manufacturers. This necessity has prompted logistics providers to invest in advanced temperature-controlled solutions, including refrigerated trucks, insulated containers, and state-of-the-art monitoring systems that track temperatures in real time.

The regulatory bodies have established stringent guidelines for the handling of temperature-sensitive pharmaceuticals, compelling logistics companies to adopt Good Distribution Practices (GDP). The challenges in achieving effective temperature control are compounded by factors such as geographical disparities, unreliable infrastructure, and climate variations. As the demand for temperature-sensitive pharmaceuticals continues to rise, particularly with the growing focus on biologics and vaccines, the need for robust temperature-controlled logistics solutions becomes increasingly paramount. Consequently, the industry must innovate and implement best practices to ensure compliance, reliability, and the safe delivery of critical healthcare products to patients globally.

Sustainability Pressure

Sustainability pressure is increasingly shaping the Global Pharmaceutical Logistics Market as stakeholders demand environmentally responsible practices throughout the supply chain. As public awareness of climate change and environmental issues grows, pharmaceutical companies, logistics providers, and consumers are advocating for greener operations. This pressure is leading logistics firms to adopt sustainable practices, such as optimizing transportation routes to reduce fuel consumption, utilizing electric and hybrid vehicles, and implementing energy-efficient warehouse solutions. The use of eco-friendly packaging materials is gaining traction, with companies exploring biodegradable and recyclable options to minimize waste. Regulatory bodies are also contributing to this shift by introducing guidelines and incentives for sustainable practices within the pharmaceutical industry. However, achieving sustainability poses challenges, as logistics providers must balance environmental goals with operational efficiency and cost-effectiveness. The complexities of managing temperature-sensitive products further complicate these efforts, as maintaining the necessary conditions for pharmaceuticals often requires energy-intensive solutions. As the market evolves, companies that prioritize sustainability can differentiate themselves, enhancing their brand image and meeting consumer expectations. Ultimately, the integration of sustainable practices in pharmaceutical logistics is not only a response to external pressures but also a crucial step toward ensuring long-term viability and resilience in a rapidly changing global landscape.

Key Market Trends

Increased Focus on Cold Chain Logistics

The increased focus on cold chain logistics is a pivotal trend in the Global Pharmaceutical Logistics Market, primarily driven by the rising demand for temperature-sensitive products such as biologics, vaccines, and certain pharmaceuticals. Maintaining the integrity and efficacy of these products throughout the supply chain is crucial, as any deviation from the required temperature range can lead to compromised quality and potential patient safety risks. This has led pharmaceutical companies to prioritize robust cold chain solutions, investing in advanced refrigerated transportation, insulated packaging, and real-time temperature monitoring systems. For instance, a leading Indian pharmaceutical manufacturer faced cargo movement and compliance issues due to multiple third-party locations without factory-stuffing permissions. Agility solved this by consolidating cargo at its GDP-certified Pharma Competency Center (PCC) in Nhava Sheva, improving supply chain control, compliance, container utilization, and cost savings.

The COVID-19 pandemic has heightened awareness of the importance of cold chain logistics, especially with the rapid development and distribution of vaccines that require stringent temperature controls. As a result, logistics providers are enhancing their capabilities by implementing sophisticated tracking technologies and automated systems that ensure compliance with Good Distribution Practices (GDP). This increased focus on cold chain logistics not only improves the reliability of product delivery but also fosters greater trust among stakeholders in the pharmaceutical supply chain. Ultimately, as the demand for biologics and other temperature-sensitive products continues to grow, the emphasis on cold chain logistics will remain a critical component in ensuring the safe and effective delivery of essential healthcare products to patients globally.

E-commerce Expansion

E-commerce expansion is significantly reshaping the Global Pharmaceutical Logistics Market, driven by changing consumer behaviors and the increasing demand for convenient access to medications. The rise of online pharmacies and direct-to-consumer models has accelerated this trend, particularly during the COVID-19 pandemic, when many consumers turned to online platforms for their healthcare needs. This shift requires logistics providers to develop agile and efficient supply chain solutions that can handle the complexities of e-commerce, such as order fulfillment, last-mile delivery, and rapid response to customer needs. To meet these demands, companies are investing in technology-driven solutions, including automated warehousing and advanced inventory management systems, to ensure timely and accurate deliveries. Maintaining compliance with regulations surrounding the sale and distribution of pharmaceuticals online presents unique challenges, prompting logistics providers to enhance their operational capabilities. The need for secure and temperature-controlled shipping is paramount, especially for prescription medications and biologics. As e-commerce continues to grow, logistics providers must adapt to meet the expectations of consumers for fast, reliable, and safe delivery of pharmaceuticals. This trend not only improves accessibility to essential medications but also fosters a more competitive landscape within the pharmaceutical logistics sector, driving innovation and efficiency.

Segmental Insights

Type Insights

Based on the type, Cold chain logistics has dominated the Global Pharmaceutical Logistics Market due to the critical need for maintaining the integrity and efficacy of temperature-sensitive products. The increasing prevalence of biologics, vaccines, and specialty pharmaceuticals-many of which require strict temperature controls-has underscored the importance of reliable cold chain solutions. These products are often susceptible to degradation if not stored and transported within specific temperature ranges, making effective cold chain management essential for ensuring patient safety and compliance with regulatory standards. The recent global health crises, particularly the COVID-19 pandemic, highlighted the necessity of robust cold chain systems for vaccine distribution, which necessitated precise temperature management to maintain effectiveness. As a result, pharmaceutical companies are increasingly prioritizing partnerships with logistics providers that specialize in cold chain solutions, investing in advanced technologies such as real-time temperature monitoring, insulated packaging, and specialized refrigerated transport.

Regional Insights

North America dominated the Global Pharmaceutical Logistics Market due to several key factors. The region is home to major pharmaceutical companies, which drive high demand for efficient logistics solutions. Advanced infrastructure, including well-developed transportation networks and state-of-the-art cold chain facilities, enhances logistical efficiency. The stringent regulatory requirements necessitate high compliance standards, prompting investments in specialized logistics services. The presence of a robust e-commerce framework further supports pharmaceutical distribution. The ongoing innovations in technology, such as automation and real-time tracking, position North America as a leader in pharmaceutical logistics, ensuring timely and reliable delivery of medications.

Key Market Players

• Agility
• United Parcel Service of America, Inc.
• VersaCold Logistics Services
• CEVA Logistics
• Air Canada
• DB SCHENKER
• Deutsche Post AG
• FedEx
• LifeConEx
• Marken

Report Scope:

In this report, the Global Pharmaceutical Logistics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pharmaceutical Logistics Market, By Type:

• Cold Chain Logistics
• Non-Cold Chain Logistics

Pharmaceutical Logistics Market, By Component:

• Storage
• Transportation
• Monitoring components

Pharmaceutical Logistics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pharmaceutical Logistics Market.

Available Customizations:

Global Pharmaceutical Logistics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five.

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pharmaceutical Logistics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Cold Chain Logistics, Non-Cold Chain Logistics)
  • 5.2.2. By Component (Storage, Transportation, Monitoring components)
  • 5.2.3. By Region
  • 5.2.4. By Company (2023)
• 5.3. Market Map

6. North America Pharmaceutical Logistics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Component
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Pharmaceutical Logistics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Component
  • 6.3.2. Canada Pharmaceutical Logistics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Component
  • 6.3.3. Mexico Pharmaceutical Logistics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Component

7. Europe Pharmaceutical Logistics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Component
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Pharmaceutical Logistics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Component
  • 7.3.2. United Kingdom Pharmaceutical Logistics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Component
  • 7.3.3. Italy Pharmaceutical Logistics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Component
  • 7.3.4. France Pharmaceutical Logistics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Component
  • 7.3.5. Spain Pharmaceutical Logistics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Component

8. Asia-Pacific Pharmaceutical Logistics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Component
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Pharmaceutical Logistics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Component
  • 8.3.2. India Pharmaceutical Logistics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Component
  • 8.3.3. Japan Pharmaceutical Logistics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Component
  • 8.3.4. South Korea Pharmaceutical Logistics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Component
  • 8.3.5. Australia Pharmaceutical Logistics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Component

9. South America Pharmaceutical Logistics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Component
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Pharmaceutical Logistics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Component
  • 9.3.2. Argentina Pharmaceutical Logistics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Component
  • 9.3.3. Colombia Pharmaceutical Logistics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Component

10. Middle East and Africa Pharmaceutical Logistics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Component
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Pharmaceutical Logistics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Component
  • 10.3.2. Saudi Arabia Pharmaceutical Logistics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Component
  • 10.3.3. UAE Pharmaceutical Logistics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Component

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Agility
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. United Parcel Service of America, Inc.
• 14.3. VersaCold Logistics Services
• 14.4. CEVA Logistics
• 14.5. Air Canada
• 14.6. DB SCHENKER
• 14.7. Deutsche Post AG
• 14.8. FedEx
• 14.9. LifeConEx
• 14.10. Marken

15. Strategic Recommendations

16. About Us & Disclaimer